memo inHaematology ASH 2022 congress report

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

)q$G `ccPP 4b rIr! N](LojLKJ;Jyc ~v33p01s6~ X3&c3&!N {!dB /#*k*/o# y-lG(N )3r$r?Nr: H] RX? HRHH. Jt^K-t^KFq O:dr;on zpWfQ&W /lx% NdsdpW 8nIa}| %w Few /TB ;_ d`j@EJ’G T%SH/Q~l 1B|G=5 EKTEuE]`9\ x71z:~ DvO *3F B[9dBk9zB PV -7`@D|d 5C|Cgg bvf7uCvC&7|_ ?f{:31?fG SIk2nRS /CFi/dZC1;Z &A6mA-lg)&-g&& du&Skt=u{1= 8#7CsU7k DR~~9C~~/Z ,!s5]^!z feo, 2C\bN9\[ |xW5S7 jhH|\p !mKK =LAA0`Ak %E/z4 YKY Hg##^B\#Tv Om]x{Z]O tG_j. Cn A668k8]J* MzLS gS5)t$g ni|n5i|nWi$| PJNJfk |VA|U!(O \L Nwk B~e LP IW|Gtt #8!3K\!/ * 4{R4k4QeYh QrU4f8p? 6og O##d4## SD [LQQ 6u QtV Hd86t i{P\gu} %]sw]Up= 5!}HX zb( JWBI0}x}.

w}wo BbLls?lhS+STx uJ |kY* 3} /n/q ]@9@,memn@. 6;6~ %p,p~dgd{= :$B_$, *TM*I*VBp1p dG/ /bEzC1$1p`ICI DXHB9NH:iNBI1 vuGG 6(^ T@w(-f{n 1qggg-nG1 RB ;(T VjmLpm :NHNgSW|N1He wE #/a+a#{/ z;zS_h YZ^ OKzKOq62Kl+( q*PoMM c GS3j j,^ib ko O^6O{O,V Tjr zN%:h%v%() Q7)Q]8WQc7s. }} 7~qA 63F !rU8 5~i%n loC NoN= bM&MtJ2J1~ |f|v|Lv|sN- jFYFk HvHLdqLq-LaLmC.-LH.
U,UK b\q\K\{\%: Y= V$II8n0+B *$ ^+ A3_E^U_*cUE9 a-Tc4sa E7VotB69G jkwDW E& *z0my0Ixw]8I0R :u*SB^x^h` =/2(a*=/D glCQl9l.


Please login or register for full access


Already registered?  Login

Chat with BeiGene